Literature DB >> 12573518

Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat.

D P Figlewicz1, S B Evans, J Murphy, M Hoen, D G Baskin.   

Abstract

Recent studies have demonstrated that the metabolic hormones insulin and leptin can modulate behavioral performance in reward-related paradigms. However, specific anatomical substrate(s) within the CNS for these effects remain to be identified. We hypothesize that midbrain dopamine neurons, which have been implicated to be critical in the mediation of motivational and reward aspects of stimuli, contribute to these behavioral effects of insulin and leptin. As one approach to evaluate this hypothesis, we used double-labeling fluorescence immunohistochemistry to determine whether the midbrain dopamine neurons express insulin receptors or leptin receptors. Extensive co-expression of tyrosine hydroxylase (a marker for dopamine neurons) with both the insulin receptor and the leptin receptor was observed in the ventral tegmentum and substantia nigra. These findings suggest that midbrain dopamine neurons are direct targets of insulin and leptin, and that they participate in mediating the effects of these hormones on reward-seeking behavior.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573518     DOI: 10.1016/s0006-8993(02)04087-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  185 in total

1.  Leptin resistance does not induce hyperphagia in the rat.

Authors:  Takashi Higuchi; Akiko Mizuno; Kazumi Narita; Toru Ichimaru; Takuya Murata
Journal:  J Physiol Sci       Date:  2011-12-06       Impact factor: 2.781

2.  Food restriction increases acquisition, persistence and drug prime-induced expression of a cocaine-conditioned place preference in rats.

Authors:  Danielle Zheng; Soledad Cabeza de Vaca; Kenneth D Carr
Journal:  Pharmacol Biochem Behav       Date:  2011-10-29       Impact factor: 3.533

3.  A progressive ratio schedule of self-stimulation testing in rats reveals profound augmentation of d-amphetamine reward by food restriction but no effect of a "sensitizing" regimen of d-amphetamine.

Authors:  Soledad Cabeza de Vaca; Lisa L Krahne; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2004-02-20       Impact factor: 4.530

Review 4.  Common cellular and molecular mechanisms in obesity and drug addiction.

Authors:  Paul J Kenny
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

5.  The act of voluntary wheel running reverses dietary hyperphagia and increases leptin signaling in ventral tegmental area of aged obese rats.

Authors:  Alexandra Shapiro; Kit-Yan Cheng; Yongxin Gao; Dong-Oh Seo; Steve Anton; Christy S Carter; Yi Zhang; Nihal Tumer; Philip J Scarpace
Journal:  Gerontology       Date:  2010-09-24       Impact factor: 5.140

Review 6.  Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses.

Authors:  A C Reichelt; R F Westbrook; M J Morris
Journal:  Br J Pharmacol       Date:  2015-11-01       Impact factor: 8.739

7.  Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism.

Authors:  Sonja K Billes; Stephanie E Simonds; Michael A Cowley
Journal:  Mol Metab       Date:  2012-07-27       Impact factor: 7.422

Review 8.  Insulin signaling and addiction.

Authors:  Lynette C Daws; Malcolm J Avison; Sabrina D Robertson; Kevin D Niswender; Aurelio Galli; Christine Saunders
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

9.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

10.  Insulin modulates the strong reinforcing effects of nicotine and changes in insulin biomarkers in a rodent model of diabetes.

Authors:  Bryan Cruz; Rodolfo J Flores; Kevin P Uribe; Evangelina J Espinoza; Charles T Spencer; Katherine M Serafine; Arbi Nazarian; Laura E O'Dell
Journal:  Neuropsychopharmacology       Date:  2019-01-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.